<DOC>
	<DOCNO>NCT02339753</DOCNO>
	<brief_summary>Carboplatin widely use conditioning regimen autologous hematopoietic stem cell transplantation pediatric solid tumor , pharmacokinetics evaluate pediatric stem cell transplantation . As carboplatin renal toxicity , pharmacokinetic study carboplatin would help safe effective administration carboplatin transplantation patient . Especially , dose carboplatin high conditioning chemotherapy , result high toxicity . Carboplatin drug mostly excrete kidney , dose carboplatin recommend accord body surface area kidney function , represent glomerular filtration rate . After analyze pharmacokinetics carboplatin , analyse also do method determine appropriate carboplatin dose .</brief_summary>
	<brief_title>Pharmacokinetic Study Carboplatin Pediatric Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description>Purpose 1 . Primary objective : To evaluate pharmacokinetics carboplatin pediatric HSCT patient . 2 . Secondary objective : To evaluate toxicity HSCTs use carboplatin condition regimen . To compare pharmacokinetics carboplatin adult child . Eligibility Inclusion criteria 1 . Patients undergo HSCT condition regimen include carboplatin . 2 . Age 19 year . 3 . Performance status : ECOG 0-2 . 4 . Patients must free significant functional deficit major organ , follow eligibility criterion may modify individual case . 1 . Heart : shortening fraction &gt; 30 % ejection fraction &gt; 45 % . 2 . Liver : total bilirubin &lt; 2 × upper limit normal ; ALT &lt; 3 × upper limit normal . 3 . Kidney : creatinine &lt; 2 × normal creatinine clearance ( GFR ) &gt; 60 ml/min/1.73m2 . 5 . Patients must lack active viral infection active fungal infection . 6 . Patients ( one parent patient age &lt; 19 ) sign inform consent . Exclusion criteria 1 . Pregnant nursing woman . 2 . Malignant nonmalignant illness uncontrolled whose control may jeopardize complication study therapy . 3 . Psychiatric disorder would preclude compliance . 4 . If clinician decides condition improper clinical study .</detailed_description>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>1 . Patients undergo HSCT condition regimen include carboplatin . 2 . Age 19 year . 3 . Performance status : ECOG 02 . 4 . Patients must free significant functional deficit major organ , follow eligibility criterion may modify individual case . 1 . Heart : shortening fraction &gt; 30 % ejection fraction &gt; 45 % . 2 . Liver : total bilirubin &lt; 2 × upper limit normal ; ALT &lt; 3 × upper limit normal . 3 . Kidney : creatinine &lt; 2 × normal creatinine clearance ( GFR ) &gt; 60 ml/min/1.73m2 . 5 . Patients must lack active viral infection active fungal infection . 6 . Patients ( one parent patient age &lt; 19 ) sign inform consent . 1 . Pregnant nursing woman . 2 . Malignant nonmalignant illness uncontrolled whose control may jeopardize complication study therapy . 3 . Psychiatric disorder would preclude compliance . 4 . If clinician decides condition improper clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>